IRVINE, Calif.--(BUSINESS WIRE)--Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against NantHealth, Inc. (“NantHealth” or the “Company”) (Nasdaq: NH). Investors who purchased or otherwise acquired NantHealth shares between February 19, 2013 and March 1, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the May 2, 2017 lead plaintiff deadline.
If you purchased shares of NantHealth during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at email@example.com.
There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.
STAT, a news organization centered on medical industry reporting, published an article claiming that NantHealth founder, Patrick Soon-Shiong, had conferred $12 million to the University of Utah through tax-exempt entities that he controlled.
The contract necessitated the University to expend most of these funds into NantHealth. STAT claims the plan allowed the Company to falsely inflate the number of test orders it reported to shareholders. When this information was offered to the investing public, NantHealth stock dropped, causing investors harm.
If you wish to learn more about this lawsuit at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at firstname.lastname@example.org.
This press release may constitute Attorney Advertising in some jurisdictions.